Dr. Hutson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3410 Worth St
Dallas, TX 75246Phone+1 214-370-1000Fax+1 214-370-1202- Is this information wrong?
Summary
- Dr. Thomas Hutson is an oncologist in Dallas, TX and is affiliated with multiple hospitals in the area, including Baylor University Medical Center, Medical City Dallas, and Baylor Institute for Rehabilitation. He received his medical degree from Ohio University College of Osteopathic Medicine and has been in practice 20 years. He specializes in genitourinary oncology and melanoma and is experienced in hematologic oncology, prostate cancer, gynecologic oncology, urologic oncology, and bladder cancer.
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2001 - 2004
- Cleveland Clinic FoundationResidency, Internal Medicine, 1997 - 2000
- Ohio University Heritage College of Osteopathic Medicine in AthensClass of 1997
Certifications & Licensure
- TX State License 2003 - 2024
- OH State License 1993 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- Top Doc
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACP) American College of Physicians, 2007
Clinical Trials
- Gemzar, Cisp, Sunitinib Urothelial Ca Start of enrollment: 2008 Aug 01
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Start of enrollment: 2010 Jan 01
- First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase ...Robert J Motzer, Toni K Choueiri, Thomas Hutson, Sun Young Rha, Javier Puente, Aly-Khan A Lalani, Eric Winquist, Masatoshi Eto, Naveen S Basappa, Nizar M Tannir, Ulka ...> ;European Urology. 2024 Apr 5
- 1 citationsLenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase...Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime Merchan, Jeffrey C Goh, Aly-Khan A...> ;Journal of Clinical Oncology. 2024 Apr 10
- 1 citationsPlain language summary looking at how long side effects last after treatment with axitinib is stopped in people with advanced renal cell carcinoma.Brian I Rini, Michael B Atkins, Toni K Choueiri, Rosemary E Teresi, Brad Rosbrook, Maghull Thakur, Thomas E Hutson> ;Future Oncology. 2023 Dec 1
- Join now to see all
Journal Articles
- Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaRobert Motzer, Thomas E Hutson, Jaime R Merchan, Corina E Dutcus, Rodolfo F Perini, Toni K Choueiri, The New England Journal of Medicine
- Publisher Correction: Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Ca...Michael B Atkins, Mario Sznol, Robert J Motzer, Richard W Joseph, Thomas Hutson, John Hainsworth, W Kimryn Rathmell, Brian I Rini, David F McDermott, Toni K Choueiri, ..., Nature
- Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell CarcinomaMichael B Atkins, Thomas Hutson, Mario Sznol, Toni K Choueiri, Sumanta K Pal, Richard W Joseph, John Hainsworth, W Kimryn Rathmell, David F McDermott, Robert J Motzer,..., Nature
Press Mentions
- Managing Side Effects of Kidney Cancer TreatmentsDecember 13th, 2022
- Dr. Thomas Hutson: Clearing the Record on Kidney CancerApril 7th, 2020
- Active Lifestyles May Help Nerves to Heal After Spinal InjuriesMay 7th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
- Fellow
Hospital Affiliations
- Baylor University Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: